Lv Weina, Lin Yan
Objective Observing the clinical effect of iodine phosphate injection combined blood perfusion in the treatment of organic phosphorus poisoning. Methods This study is a prospective study, with 96 patients with organic phosphorus poisoning admitted to our hospital from January 2022 to December 2023. They were randomly divided into a drug group (48 cases) and a combination group (48 cases) using a computer randomization method. The drug group received blood perfusion surgery, while the combination group received iodine phosphate injection combined blood perfusion surgery. The CHE activity, symptom relief, inflammatory indicators, organ damage, and prognosis of the two groups of patients were compared. Results Under different treatment regimens, the CHE activity levels in the combination group after 24 hours, 48 hours, and 72 hours of treatment were (68.33±10.25)%, (75.29±10.43)%, and (85.36±10.24)%, higher than he drug group [(63.29±10.44)%, (70.32±10.34)%, and (80.29±10.47)%] (t=2.387,2.345,2.399; P<0.05); the central nervous system symptoms, muscarinic like symptoms, nicotinic like symptoms, respiratory system symptoms disappearance time, and hospital stay in the combination group were (4.23±1.25) h, (0.55±0.14) h, and (1.34±1.25) h, (0.85±0.19) h, and (5.75±1.32) d,lower than those in the drug group [(5.18±1.44) h, (0.83±0.21) h, (1.81±0.45) h, (1.21±0.51) h, (6.61±1.75) d] (t=3.452,7.686,6.205,4.583,2.718; P<0.05); CRP, PCT and IL-6 in the combination group were (5.32±1.24) mg/L, (0.52±0.13) μg/L, and (140.23±20.22) pg/ml,lower than the drug group [(6.21±1.49) mg/L, (0.88±0.21) μg/L, (155.39±20.45) pg/ml] (t=3.287,10.099,3.652; P<0.05); LDH, AST, and SCr in the combination group were (230.35±20.46) U/L, (38.44±5.28) U/L, and (160.25±20.33) μmol/L, lower than the drug group [(245.22±20.33) μmol/L, respectively 32) U/L, (41.35±5.36) U/L, (175.33±20.41) μmol/L [t=3.573,2.670,3.627; P<0.05]; the incidence of adverse prognosis in the combination group was 4.17% (2/48) lower than the drug group 20.83% (10/48) (x2=6.095; P<0.05). Conclusion Iodine phosphate injection combined blood perfusion can effectively reduce CHE activity in patients with organic phosphorus poisoning, promote symptom recovery, alleviate inflammatory reactions, organ damage, and improve prognosis.